Get the Latest Lung Cancer News in Your Inbox
-
2024 ASCO: Highlights of Lung Cancer Research
Read time: 8 minutes Thousands of oncologists, scientists, biotech and pharmaceutical representatives, patients, and advocates (including LUNGevity staff) met to discuss lifesaving -
Is Lung Cancer in Young Adults Hereditary?
Read time: 2 minutes The question of whether lung cancer is hereditary is becoming increasingly important in the lung cancer community. While the average age of lung cancer -
Researcher Aims to Bring 360-Degree Care to Young Adults Living with Lung Cancer
Read time: 4 minutes Young adults (less than 50 years of age) are being diagnosed with lung cancer at increasing rates. They tend to be women of Hispanic or Asian descent and are -
Leveraging Basic Science to Stop Drug Resistance in RET+ Lung Cancer
Read time: 4 minutes Advances in targeted therapies have allowed us to treat some types of lung cancer with mutations in specific genes (for example, EGFR, KRAS, and RET). This has -
Highlights of AACR 2024: Where the Laboratory Meets the Patient
Research and treatment updates from the 2024 American Association for Cancer Research meeting—NSCLC, SCLC, ALK, EGFR, RET, KRAS, MET, Immunotherapy. -
Working to Diagnose Lung Cancer Earlier in Hispanic Communities
Read time: 4 minutes Lung cancer screening guidelines were first issued by the United States Preventive Services Task Force in 2013 to help doctors find lung cancer in its earliest